Hunt Douglas M's Form 4 filing
Puma Biotechnology, Inc. (PBYI) · filed Oct 6, 2021
- Accession no.
- 0001437749-21-023377
- Filed
- Oct 6, 2021
- Trade date
- Oct 4, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $2.72K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hunt Douglas MCIK 0001727172 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | SSaleDisposed | −443 | $6.15 | −$2,724.45 | 65,658 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.